Using data from the French National TMA registry, study authors evaluated the demographic and clinical characteristics of thrombotic microangiopathy in autoimmune diseases, and assessed therapeutic approaches.
Researchers conducted a nationwide cohort study to determine the association between autoimmune inflammatory rheumatic diseases and COVID-19 in South Korea, early in the pandemic.
Researchers aimed to examine behavioral patterns with regard to vaccination against SARS-CoV-2 to identify pragmatic actions to increase vaccine coverage in this population.
Study authors reported on the reactivation of herpes zoster following mRNA COVID-19 vaccination in some patients with autoimmune inflammatory rheumatic diseases.
The safety and efficacy of immune checkpoint inhibition in patients with advanced melanoma with and without autoimmune disease was assessed.
A collaboration between clinicians, researchers, and authors in rheumatology, ophthalmology, dermatology, and pulmonology for National Autoimmune Disease Awareness Month in March.
In this interview, Laurent Arnaud, MD, PhD, and Laura Boekel, MD, each discuss findings from their studies on the perspectives and concerns of patients with autoimmune diseases regarding COVID-19 vaccination.
For patients with advanced melanoma, response to immune checkpoint inhibitors is similar for those with and without preexisting autoimmune disease.
This study compared survival outcomes in patients with lung cancer with and without an existing autoimmune disorder.
Autoimmune disease comorbidity among adults with atopic dermatitis is common.
